4//SEC Filing
Goldstein David S. 4
Accession 0001140361-11-056992
CIK 0001375247other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 2:42 PM ET
Size
11.4 KB
Accession
0001140361-11-056992
Insider Transaction Report
Form 4
Goldstein David S.
Executive Vice President
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2011-12-09−33,334→ 16,666 totalExercise: $5.86Exp: 2019-03-03→ Common Stock (33,334 underlying) - Exercise/Conversion
Common Stock
2011-12-09$5.86/sh+33,334$195,337→ 33,334 total - Sale
Common Stock
2011-12-09$9.75/sh−21,500$209,625→ 0 total - Sale
Common Stock
2011-12-09$9.75/sh−33,334$325,007→ 0 total - Sale
Common Stock
2011-12-08$9.84/sh−1,000$9,841→ 21,500 total
Footnotes (2)
- [F1]Such transaction was executed in multiple trades at prices ranging from $9.80 to $9.86. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the trades were effected.
- [F2]Fully vested and immediately exercisable.
Documents
Issuer
Obagi Medical Products, Inc.
CIK 0001375247
Entity typeother
Related Parties
1- filerCIK 0001382901
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 2:42 PM ET
- Size
- 11.4 KB